EUVIMEDEUVIMED entdecken
Crossref

A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells

Hafkenscheid K., Jacuinde B., Mari A., Gomez A., Philip C., Jay P., Diaz AJ., Wang T.

American Journal of Medical Sciences and Medicine · 09.07.2026 · 14 (2) · 25-31

DOI: 10.12691/ajmsm-14-2-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Sciences and Medicine, erschienen am 09.07.2026. Verfasst von Hafkenscheid K. und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

K., H., B., J., A., M., A., G., C., P., P., J., AJ., D., & T., W. (2026). A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells. American Journal of Medical Sciences and Medicine, 14(2), 25-31. https://doi.org/10.12691/ajmsm-14-2-2

Vancouver

K. H, B. J, A. M, A. G, C. P, P. J, et al. A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells. American Journal of Medical Sciences and Medicine. 2026;14(2):25-31. doi:10.12691/ajmsm-14-2-2

BibTeX
@article{K2026,
  author = {K., Hafkenscheid and B., Jacuinde and A., Mari and A., Gomez and C., Philip and P., Jay and AJ., Diaz and T., Wang},
  title = {A Bimodal Model of Temozolomide-mediated LSD1 Activity in Glioma Cells},
  journal = {American Journal of Medical Sciences and Medicine},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {25--31},
  doi = {10.12691/ajmsm-14-2-2}
}
Kostenlos starten →